Literature DB >> 342554

A topical treatment program for psoriasis with low anthralin concentrations.

I Brody, A Johansson.   

Abstract

A treatment program for psoriasis in which 0.01--0.05% anthralin was used has been clinically evaluated. In such low concentrations it is possible to use anthralin if one simultaneously avoids exposing the skin to unnecessary external mechanical trauma, including the mechanical removal of the scales from the lesions. Applied in this fashion, anthralin then also becomes most suitable for use in ambulatory therapy. In these low concentrations it does not irritate either the involved or the non-involved psoriatic skin. No discoloration of the clothes, the skin, the hair or the nails was observed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 342554     DOI: 10.1111/j.1600-0560.1977.tb00912.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

1.  Dermatology-epitomes of progress: newer aspects of the use of anthralin in psoriasis.

Authors:  L H Goldberg; M Stewart
Journal:  West J Med       Date:  1981-01

Review 2.  Psoriasis. A review of recent advances in treatment.

Authors:  E M Farber; L Nall
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

Review 3.  Psoriasis therapy: a current perspective.

Authors:  N J Lowe
Journal:  West J Med       Date:  1983-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.